220 related articles for article (PubMed ID: 33413085)
21. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
Sarkar JP; Saha I; Seal A; Maity D; Maulik U
Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
[TBL] [Abstract][Full Text] [Related]
22. Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2).
Sessa F; Salerno M; Pomara C
Medicina (Kaunas); 2021 Mar; 57(4):. PubMed ID: 33806100
[TBL] [Abstract][Full Text] [Related]
23. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
Abdelrahman Z; Li M; Wang X
Front Immunol; 2020; 11():552909. PubMed ID: 33013925
[TBL] [Abstract][Full Text] [Related]
24. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
Ye ZW; Jin DY
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
[TBL] [Abstract][Full Text] [Related]
25. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
[TBL] [Abstract][Full Text] [Related]
26. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
[TBL] [Abstract][Full Text] [Related]
27. Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
Kohli A; Sauerhering L; Fehling SK; Klann K; Geiger H; Becker S; Koch B; Baer PC; Strecker T; Münch C
Life Sci Alliance; 2022 May; 5(5):. PubMed ID: 35110370
[TBL] [Abstract][Full Text] [Related]
28. Broad-spectrum coronavirus antiviral drug discovery.
Totura AL; Bavari S
Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
[TBL] [Abstract][Full Text] [Related]
29. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.
Rathore JS; Ghosh C
Pathog Dis; 2020 Aug; 78(6):. PubMed ID: 32840560
[TBL] [Abstract][Full Text] [Related]
30. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
Front Immunol; 2020; 11():1949. PubMed ID: 32849654
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses.
Menachery VD; Eisfeld AJ; Schäfer A; Josset L; Sims AC; Proll S; Fan S; Li C; Neumann G; Tilton SC; Chang J; Gralinski LE; Long C; Green R; Williams CM; Weiss J; Matzke MM; Webb-Robertson BJ; Schepmoes AA; Shukla AK; Metz TO; Smith RD; Waters KM; Katze MG; Kawaoka Y; Baric RS
mBio; 2014 May; 5(3):e01174-14. PubMed ID: 24846384
[TBL] [Abstract][Full Text] [Related]
32. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
Wang Y; Grunewald M; Perlman S
Methods Mol Biol; 2020; 2203():1-29. PubMed ID: 32833200
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
Marston JL; Greenig M; Singh M; Bendall ML; Duarte RRR; Feschotte C; Iñiguez LP; Nixon DF
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34731091
[TBL] [Abstract][Full Text] [Related]
34. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.
Di Maria E; Latini A; Borgiani P; Novelli G
Hum Genomics; 2020 Sep; 14(1):30. PubMed ID: 32917282
[TBL] [Abstract][Full Text] [Related]
35. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
Zhang YY; Li BR; Ning BT
Front Immunol; 2020; 11():2033. PubMed ID: 32922406
[TBL] [Abstract][Full Text] [Related]
36. SARS and MERS: recent insights into emerging coronaviruses.
de Wit E; van Doremalen N; Falzarano D; Munster VJ
Nat Rev Microbiol; 2016 Aug; 14(8):523-34. PubMed ID: 27344959
[TBL] [Abstract][Full Text] [Related]
37. Animal models for emerging coronavirus: progress and new insights.
Yuan L; Tang Q; Cheng T; Xia N
Emerg Microbes Infect; 2020 Dec; 9(1):949-961. PubMed ID: 32378471
[TBL] [Abstract][Full Text] [Related]
38. Animal models for SARS and MERS coronaviruses.
Gretebeck LM; Subbarao K
Curr Opin Virol; 2015 Aug; 13():123-9. PubMed ID: 26184451
[TBL] [Abstract][Full Text] [Related]
39. Interspecies Jumping of Bat Coronaviruses.
Wong ACP; Lau SKP; Woo PCY
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834994
[TBL] [Abstract][Full Text] [Related]
40. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.
Singh A; Singh RS; Sarma P; Batra G; Joshi R; Kaur H; Sharma AR; Prakash A; Medhi B
Virol Sin; 2020 Jun; 35(3):290-304. PubMed ID: 32607866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
